SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2002
---------------
IMS HEALTH INCORPORATED
------------------------
(Exact name of registrant as specified in its charter)
Delaware 001-14049 06-1506026
-------- --------- ----------
(State of (Commission File Number) (IRS Employer
incorporation) Identification No.)
1499 Post Road
Fairfield, Connecticut 06824
---------------------- -----
(Address of principal executive offices) (Zip Code)
(203) 319-4700
--------------
(Registrant's telephone number,
including area code)
N/A
--------------------------------------------------------------------
(Former name or former address, if changed since last report)
Items 1-6. Not Applicable.
Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Financial Statements.
None
(b) Pro Forma Financial Information.
None
(c) Exhibits
99.1 Statement under Oath of Principal Executive Officer of IMS Health
Incorporated
99.2 Statement under Oath of Principal Financial Officer of IMS Health
Incorporated
99.3 Certification of Chief Executive Officer Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002
99.4 Certification of Chief Financial Officer Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002
99.5 Press Release of the Registrant dated August 12, 2002
Item 8. Not Applicable.
Item 9. REGULATION FD DISCLOSURE.
On August 12, 2002, IMS Health Incorporated transmitted for filing with the
Securities and Exchange Commission the Statements under Oath of its Principal
Executive Officer and Principal Financial Officer in accordance with the order
of the Commission dated June 27, 2002, requiring the filing of sworn statements
pursuant to Section 21(a)(1) of the Securities Exchange Act of 1934. Copies of
the statements are attached hereto as Exhibits 99.1 and 99.2 and are
incorporated herein by reference.
In addition, on August 12, 2002, IMS Health Incorporated furnished to the
Securities and Exchange Commission certifications of its Chief Executive Officer
and Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Copies of the
certifications are attached hereto as Exhibits 99.3 and 99.4 and are
incorporated herein by reference.
Finally, on August 12, 2002, IMS Health Incorporated issued a press release
announcing the filing of the statements and certifications described above. A
copy of the press release is attached hereto as Exhibit 99.5 and incorporated
by reference herein.
In accordance with General Instruction B.2. of Form 8-K, the information
included or incorporated in this report, including Exhibits 99.1, 99.2, 99.3,
99.4 and 99.5, shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, nor shall such information and exhibits be
deemed incorporated by reference in any filing under the Securities Act of 1933,
except as shall be set forth by specific reference in such a filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
IMS HEALTH INCORPORATED
By: /s/ Robert H. Steinfeld
-----------------------
Name: Robert H. Steinfeld
Title: Senior Vice President, General
Counsel and Corporate Secretary
Date: August 12, 2002